Iliofemoral deep venous thrombosis: Safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy

Keyphrases

• Safety Outcomes 100%
• Efficacy Outcomes 100%
• Thrombolytic Therapy 100%
• Iliofemoral Deep Venous Thrombosis 100%
• Catheter-directed 100%
• Technical Success 50%
• Stent Placement 50%
• Iliac Vein 50%
• Femoral Vein 50%
• Angioplasty 25%
• Bleeding 25%
• Pulmonary Embolism 25%
• Transfusion 25%
• Clinical Benefit 25%
• Recent-onset 25%
• Clinical Analysis 25%
• Consecutive Patients 25%
• Hematoma 25%
• Previous History 25%
• Symptom Onset 25%
• Major Complications 25%
• Mechanical Thrombectomy 25%
• Urokinase 25%
• Malignant Disease 25%
• Infusion Catheter 25%
• Primary Patency 25%
• Secondary Patency 25%
• Patency Rate 25%
• Venous Patency 25%

Medicine and Dentistry

• Deep Vein Thrombosis 100%
• Fibrinolytic Therapy 100%
• Infusion 50%
• Thrombolytic Drug 50%
• Stent Placement 50%
• Femoral Vein 50%
• Iliac Vein 50%
• Limb 25%
• Angioplasty 25%
• Pulmonary Embolism 25%
• Hematoma 25%
• Mechanical Thrombectomy 25%
• Urokinase 25%
• Diseases 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Fibrinolytic Agent 100%
• Deep Vein Thrombosis 100%
• Lung Embolism 20%
• Urokinase 20%
• Hematoma 20%
• Diseases 20%